You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,406,906


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,406,906
Title: Cerebral therapeutic agent and its use
Abstract:The invention provides pharmaceutical compositions and medicaments, useful for the treatment of cerebral disorders, wherein the active compound is 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl)-pyridine-3-(.beta.-methoxyethy l ester)-5-(isopropyl ester). Also included in the invention are methods for the use of said compositions and medicaments.
Inventor(s): Meyer; Horst (Wuppertal, DE), Bossert; Friedrich (Wuppertal, DE), Kazda; Stanislav (Wuppertal, DE), Hoffmeister; Friedrich (Wuppertal, DE), Vater; Wulf (Leverkusen, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:06/346,319
Patent Claim Types:
see list of patent claims
Use; Delivery;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,406,906

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 4,406,906, exploring its claims, scope, and the broader patent landscape it operates within.

Background of Patent 4,406,906

To begin, it is essential to identify the patent in question. United States Patent 4,406,906, though not specified in the provided sources, would typically be found through the USPTO's patent search database[1].

How to Search for Patents

To find detailed information about Patent 4,406,906, one would use the USPTO's search facilities. The USPTO Public Search Facility in Alexandria, VA, or local Patent and Trademark Resource Centers (PTRCs) can provide access to patent and trademark information in various formats, including online, microfilm, and print[1].

Understanding Patent Claims

Patent claims define the scope of the invention and are a critical component of the patent. Research has shown that the scope of patent claims can be measured using metrics such as independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims, which are vital for determining patent quality and validity[3].

Patent Scope Analysis

  • Independent Claim Length and Count: These metrics can help in understanding how narrow or broad the claims are. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].
  • Examination Process: The patent examination process tends to narrow the scope of patent claims, making them more specific and less broad over time[3].

Subject Matter Eligibility

For any patent, including 4,406,906, subject matter eligibility is a key issue. The USPTO uses a two-pronged framework under 35 U.S.C. § 101 to determine eligibility:

  • Prong One: Determines if the claim recites an abstract idea, such as mathematical concepts or mental processes. If it does not, the claim is patent-eligible[4].
  • Prong Two: If the claim does recite an abstract idea, it must integrate the abstract idea into a practical application. This involves showing that the claims reflect an improvement in the functioning of a computer or another technical field[4].

Practical Application and Technical Improvements

To overcome section 101 rejections, it is crucial to demonstrate that the claims are directed to a specific, concrete technological advancement or solution to a technical problem. This involves building a compelling narrative around the main novelty of the claimed invention and highlighting its practical utility and real-world impact[4].

Patent Landscape and Global Considerations

  • Global Dossier: For patents with international filings, the Global Dossier service provides access to the file histories of related applications from participating IP Offices. This can help in understanding the global patent family and any relevant office actions or citations[1].
  • Common Citation Document (CCD): The CCD consolidates prior art cited by all participating offices for the family members of a patent application, facilitating a more integrated global patent system[1].

False Advertising and Patent Claims

When marketing products based on patented technologies, it is essential to avoid false claims of patent protection. Overstating the scope of patent rights can lead to false advertising claims under the Lanham Act, even without the intent to deceive the public[5].

Key Takeaways

  • Detailed Search: Use USPTO resources to find and analyze the patent.
  • Claim Analysis: Understand the scope and breadth of the patent claims.
  • Subject Matter Eligibility: Ensure the patent meets the two-pronged framework for eligibility.
  • Global Considerations: Utilize tools like Global Dossier and CCD for international context.
  • Marketing Integrity: Avoid false claims of patent protection to prevent legal issues.

FAQs

Q: How can I find detailed information about a specific patent like 4,406,906? A: You can use the USPTO's Public Search Facility, local PTRCs, or the online patent search database to find detailed information about a specific patent.

Q: What metrics can be used to measure the scope of patent claims? A: Metrics such as independent claim length and independent claim count can be used to measure the scope and breadth of patent claims.

Q: What is the significance of Prong Two in the subject matter eligibility analysis? A: Prong Two involves demonstrating that the claims integrate an abstract idea into a practical application, showing an improvement in the functioning of a computer or another technical field.

Q: How can false claims of patent protection lead to legal issues? A: False claims can lead to false advertising claims under the Lanham Act, even without the intent to deceive the public.

Q: What is the purpose of the Global Dossier service? A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, facilitating a more integrated global patent system.

Sources

  1. USPTO: Search for patents - USPTO
  2. ACUS: U.S. Patent Small Claims Court
  3. SSRN: Patent Claims and Patent Scope
  4. Baker Botts: The Importance of Prong Two of Step 2A for AI Inventions
  5. Fenwick: False Claims of Patent Protection Can Be False Advertising Under…

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,406,906

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,406,906

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany2815578Apr 11, 1978

International Family Members for US Patent 4,406,906

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 383271 ⤷  Subscribe
Austria A262179 ⤷  Subscribe
Australia 4583579 ⤷  Subscribe
Australia 532623 ⤷  Subscribe
Belgium 875457 ⤷  Subscribe
Canada 1140853 ⤷  Subscribe
Switzerland 640734 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.